Partager cette page
Projets

Call n°17

R&D

PICABO

The PICABO project aims to improve transfusion safety through a new patented technology.

Antigone, the new spinoff of the ULB, is developing in the global level a new Point of Care Testing device, which is simple to use, allowing the nursing staff to check the consistency, with total reliability, between the blood group ABO of a patient and the one of the blood bag destined for it.

This unique new system will instantly offer double checking electronic against the blood bank file and analytical by performing ABO tests of the patient and the blood bag – at the patient’s bedside. This will help to significantly reduce the risk of ABO incompatibility at the time of transfusion of the patient.

Markets

Health & Wellness

Technology

Microfluidic
Advanced Manufacturing

Consortium

Laboratoires d’Immuno-Hematologie et de Microfluidique de l’ULB